Document is current
Any future updates will be listed below
-
Authors
Izutsu, Koji https://orcid.org/0000-0001-9129-8057
Ishikawa, Takayuki
Shimada, Kazuyuki
Kubo, Kohmei
Kondo, Takeshi
Fujimoto, Katsuya
Fujisaki, Tomoaki
Kurahashi, Shingo
Nagafuji, Koji
Sakai, Rika
Jo, Tatsuro
Nakazato, Tomonori
Sunami, Kazutaka
Kasahara, Senji
Cohen, Aileen
Takai, Motohisa
Zhong, Jinhua
Takeuchi, Masahiro
- License Information
-
More Information
Article History
Received: 23 August 2024
Revised: 14 January 2025
Accepted: 15 January 2025
First Online: 17 February 2025
Declarations
:
: Takayuki Ishikawa, Kazuyuki Shimada, Kohmei Kubo, Takeshi Kondo, Tomoaki Fujisaki, Shingo Kurahashi, Rika Sakai, Tatsuro Jo, Tomonori Nakazato, Masahiro Takeuchi: No conflict of interest to disclose. Koji Izutsu: Honoraria from Ono Pharmaceutical, Janssen; research funding from AstraZeneca, AbbVie, Incyte, Bristol Myers Squibb, Novartis, Janssen, Yakult, Daiichi Sankyo, Chugai, BeiGene, Genmab. Katsuya Fujimoto: Research funding from Parexel International Co, Ltd, Insight Biosciences Japan, LLC. Kazutaka Sunami: Honoraria from Celgene, Bristol Myers Squibb, Takeda Pharmaceutical, Sanofi; research funding from Ono Pharmaceutical, MSD, Celgene, AbbVie G.K., Takeda Pharmaceutical, Sanofi, Bristol Myers Squibb, Daiichi Sankyo, Alexion Pharma, GSK, Otsuka Pharmaceutical, Novartis Pharma, Astellas, Amgen, Janssen Pharma, Chugai Pharmaceutical, Kyowa Kirin, Pfizer. Senji Kasahara: Honoraria from Daiichi Sankyo; research funding from Novartis Pharma, Astellas Pharma, Daiichi Sankyo. Aileen Cohen: Consultant and equity holder with BeiGene. Motohisa Takai, Jinhua Zhong: Employment and stock options from BeiGene. Koji Nagafuji: An editor of International Journal of Hematology during the review process.
